The Knowledge Within: An Interview With Merck KGaA’s R&D Chief

Luciano Rossetti, head of global research and development at Merck KGaA, believes the mid-sized pharma is well on its way to becoming a global immuno-oncology specialist. He discusses in-house innovation, the company’s recent IO alliance with GSK and the next wave of success that is beginning to swell across the cancer drug development community.

Merck KGaA’s Luciano Rossetti talks to In Vivo about the German pharma’s next wave of immuno-oncology products that are steadily moving through its pipeline, why GlaxoSmithKline PLC was an ideal IO partner in a very competitive cancer drug development arena and the company’s wider deal-making strategy when it comes to pipeline advancement.

In February 2019, Merck entered a global strategic alliance with GSK to jointly develop and commercialize its pipeline cancer therapy...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on In Vivo for daily insights

Start your 7-day free trial
Explore trusted news, analysis, and insights
Access comprehensive global coverage
Enjoy instant access – no credit card required

Start Free Trial

Already a subscriber?

Astellas’s New Head Of Innovation Lab Sets Fresh Direction For External R&D

Nov 06 2025

• By David Wild

Launched in April 2025, Astellas’s Innovation Lab unites fragmented research units under Morten Sogaard to pursue focused indications, a dual-track R&D strategy and tailored partnerships that balance innovation, risk and collaboration.

ResMed Taps Wearables And GLP-1 Trends To Expand Sleep Care

Nov 05 2025

• By Marion Webb

Resmed’s CMO Carlos Nunez discusses the sleep giant’s continued push from medtech into healthtech and its efforts to fix what he calls a “broken pathway” to diagnosis and treatment for millions with undetected sleep apnea.

Aviv Regev: The Computational Biologist Remaking Drug Discovery At Genentech

Oct 23 2025

• By David Wild

Aviv Regev is betting AI-driven drug discovery can transform Genentech's pipeline, with early wins validating her computational biology approach to pharmaceutical R&D.

Podcast: Essential Pharma – Following A Patient First Philosophy

Oct 17 2025

• By Anabel Costa-Ferreira

Essential Pharma CEO Emma Johnson discusses the company’s strategic priorities and plans for growth as it expands its portfolio in rare diseases.

Wealth Of MedTech Innovator Asia Pacific Entries Underlines Rising Caliber Of Local Technologies

Oct 22 2025

• By Ashley Yeo

The culmination of the MedTech Innovator APAC awards program 2025 comes later this month when the top prizes are handed out at the grand final in Singapore. But all cohort companies benefit from the competition’s mentoring process, says awards organizer Fredrik Nyberg.